Author:
Shao Pei-Lan,Lu Chun-Yi,Hsieh Yu-Chia,Bock Hans L,Huang Li-Min
Reference19 articles.
1. Benefits of combination vaccines: effective vaccination on a simplified schedule;Dodd;Am J Manag Care,2003
2. The use of combination vaccines has improved timeliness of vaccination in children;Kalies;Pediatr Infect Dis J,2006
3. Efficacy of acellular pertussis vaccine in early childhood after household exposure;Schmitt;JAMA,1996
4. Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine;Lim;Ann Acad Med Singapore,2007
5. PEDIARIX: clinical trials;Yeh;Expert Rev Vaccines,2005
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China;Human Vaccines & Immunotherapeutics;2022-01-31
2. Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study;Human Vaccines & Immunotherapeutics;2020-02-12
3. Integration of hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine within existing national recommendations following a birth dose of monovalent hepatitis B virus vaccine: results of a systematic review in the Asia Pacific region;Expert Review of Vaccines;2019-08-01
4. Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study;Human Vaccines & Immunotherapeutics;2018-11-15
5. Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants;Human Vaccines & Immunotherapeutics;2016-10-21